March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... clearance of Persona ® Revision SoluTion™ Femur, a revision knee implant component offering an alternative for patients with ...
Zacks.com on MSN6d
Should You Consider Retaining ZBH Stock in Your Portfolio Now?Zimmer Biomet's robust Knee business appears promising. However, a dull macroeconomic condition adds to the worry.
March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings ... clearance of Persona® Revision SoluTion™ Femur, a revision knee implant component offering an alternative for patients with ...
A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component, Persona Revision SoluTion Femur, to provide an option for individuals ...
Medical Device Network on MSN17d
FDA grants 510(k) clearance to Zimmer’s new revision knee implant componentThe US Food and Drug Administration (FDA) has granted 510(k) clearance to Zimmer Biomet's new revision knee implant component ...
March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback